Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 17/03/20031 min de leitura
Determination of Regulatory Review Period for Purposes of Patent Extension; VITREON; Amendment
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending its determination regarding the regulatory review period for purposes of patent extension for VITREON that appeared in the Federal Register of December 17, 1998 (63 FR 69633). FDA is amending the document because the agency agrees with the information provided in a request from the applicant for revision of the regulatory review period.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →